North Star Imaging Introduces efX-SIM™ Software

Summation

  • efX-Sim simulates standard North Star Imaging DR and CT systems which enables X-ray equipment operators to develop techniques and motion programs without having to use a physical X-ray system.
  • efX-SIM uses a sophisticated X-ray algorithm that simulates how a polychromatic x-ray beam interacts with parts, alloys, and even multiple materials at once.
  • Importing CAD files or CT scan data is simple and gives you the ability to see how your parts will interact with X-rays.

efX-SIM is North Star Imaging’s newest software technology for industrial Digital Radiography & Computed Tomography X-ray imaging. efX-Sim simulates standard North Star Imaging DR and CT systems which enables X-ray equipment operators to develop techniques and motion programs without having to use a physical X-ray system. Importing CAD files or CT scan data is simple and gives you the ability to see how your parts will interact with X-rays.

View video here.

efX-SIM uses a sophisticated X-ray algorithm that simulates how a polychromatic x-ray beam interacts with parts, alloys, and even multiple materials at once. This algorithm is GPU-accelerated, allowing the simulation to be run interactively. This means that any change to the system or parts being simulated will update the final detector image immediately, without the significant delay associated with non-interactive simulations.

Techniques and motion programs that are created in efX-Sim can be imported into the original system. Part position and orientation can even be exported to an STL file to develop 3D printable physical fixtures. Training new system operators on a digital twin is simple, risk-free, and frees up your system for other tasks.

More News

Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substance

"We are thrilled with the DEA's decision, which underscores the potential of MIRA-55 as a groundbreaking therapeutic candidate," said Erez Aminov, Chairman & CEO of MIRA Pharmaceuticals. "This ruling allows us to focus on MIRA-55's unique cognitive and anxiety benefits. With access to $90B traditional neurological and $30B cannabis markets, MIRA-55 represents a significant value proposition for our company.  We remain committed to advancing it through the development pipeline for treating these diseases from which so many currently suffer."

Abu Dhabi Issues First BioTech Inventor-Class Golden Visa to Catalyze “Made-In-Abu-Dhabi IP” to Rockefeller University Inventor Dr Kambiz Shekdar, PhD

Dr Kambiz Shekdar said: "I gratefully take this opportunity as my solemn commitment to help build up the BioTech sector in Abu Dhabi with the same home-grown can-do-and-have-done record of accomplishment demonstrated by Emirati leadership, its people, and nation, and to do so collegially with the best of the best of the world's human capital across frontier technologies who, like myself, are drawn to the UAE with the thirst to pioneer and build better like only possible in the red-hot entrepreneurial climate of the UAE."

Activation Capital Introduces ‘Frontier BioHealth’ to Catalyze Life Science Startups

"We celebrate the growing base of research and technological advances within the region's health and life sciences sector," said Chandra Briggman, President and CEO of Activation Capital.

By using this website you agree to accept Medical Device News Magazine Privacy Policy